Dashboard
1
Poor Management Efficiency with a low ROE of 11.66%
- The company has been able to generate a Return on Equity (avg) of 11.66% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 10.04
3
Positive results in Dec 24
4
With ROE of 9.53%, it has a fair valuation with a 1.89 Price to Book Value
5
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
26.9%
0%
26.9%
6 Months
0.81%
0%
0.81%
1 Year
-13.79%
0%
-13.79%
2 Years
-20.63%
0%
-20.63%
3 Years
-33.23%
0%
-33.23%
4 Years
-66.61%
0%
-66.61%
5 Years
-46.04%
0%
-46.04%
EKF Diagnostics Holdings Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.16%
EBIT Growth (5y)
-5.55%
EBIT to Interest (avg)
10.04
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.82
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.35%
ROE (avg)
11.66%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.89
EV to EBIT
17.27
EV to EBITDA
10.43
EV to Capital Employed
2.16
EV to Sales
2.37
PEG Ratio
11.11
Dividend Yield
NA
ROCE (Latest)
12.48%
ROE (Latest)
9.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
52.60
66.60
-21.02%
Operating Profit (PBDIT) excl Other Income
10.20
14.20
-28.17%
Interest
0.10
0.10
Exceptional Items
-2.80
-17.50
84.00%
Consolidate Net Profit
2.70
-9.60
128.12%
Operating Profit Margin (Excl OI)
90.30%
113.50%
-2.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -21.02% vs -18.58% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 128.12% vs -159.26% in Dec 2022
About EKF Diagnostics Holdings Plc 
EKF Diagnostics Holdings Plc
Pharmaceuticals & Biotechnology
EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Company Coordinates 
Company Details
Avon HSE, 19 Stanwell Road , PENARTH None : CF64 2EZ
Registrar Details






